| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0025-6196(12)61815-1 |
| P698 | PubMed publication ID | 7934188 |
| P2093 | author name string | E R Dickson | |
| K D Lindor | |||
| V Balan | |||
| R A Jorgensen | |||
| P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
| Dyslipoproteinaemia of liver disease | Q33688775 | ||
| Effect of ursodeoxycholic acid treatment on ileal absorption of bile acids in man as determined by the SeHCAT test | Q34394412 | ||
| The hypercholesterolaemia of obstructive jaundice | Q34471752 | ||
| Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones | Q34475740 | ||
| Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism. | Q39741204 | ||
| Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) | Q39859200 | ||
| Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients | Q41490866 | ||
| Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes | Q42161757 | ||
| Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? | Q43676662 | ||
| Modulation of bile secretion by hepatic low-density lipoprotein uptake and by chenodeoxycholic acid and ursodeoxycholic acid treatment in the hamster | Q69807272 | ||
| A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation | Q70338015 | ||
| Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids | Q71520996 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| P433 | issue | 10 | |
| P921 | main subject | lipid | Q11367 |
| primary biliary cholangitis | Q1072420 | ||
| P304 | page(s) | 923-929 | |
| P577 | publication date | 1994-10-01 | |
| P1433 | published in | Mayo Clin Proc | Q6538184 |
| P1476 | title | Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis | |
| P478 | volume | 69 |
| Q35926418 | Approach to a patient with elevated serum alkaline phosphatase |
| Q34993666 | Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease |
| Q35068031 | Current management of primary biliary cirrhosis and primary sclerosing cholangitis |
| Q45264347 | Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial |
| Q35760984 | Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis |
| Q64069796 | Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials |
| Q35960789 | Lipids and lipid-activated vitamins in chronic cholestatic diseases |
| Q35573921 | Management of osteoporosis, fat-soluble vitamin deficiencies, and hyperlipidemia in primary biliary cirrhosis |
| Q38738566 | Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis. |
| Q90707736 | Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases |
| Q26781780 | Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis: a Review Featuring a Women's Health Perspective |
| Q56428273 | Primary biliary cirrhosis |
| Q56854243 | Primary biliary cirrhosis |
| Q57141930 | Primary biliary cirrhosis |
| Q34210604 | Primary biliary cirrhosis and primary sclerosing cholangitis |
| Q55395737 | Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review. |
| Q34182672 | Treatment Options for Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis |
| Q26996051 | Treatment of dyslipidemia in allogeneic hematopoietic stem cell transplant patients |
| Q24202184 | Ursodeoxycholic acid for primary biliary cirrhosis |
| Q24241945 | Ursodeoxycholic acid for primary biliary cirrhosis |
| Q32064450 | Ursodeoxycholic acid for primary biliary cirrhosis. |
| Q72999026 | Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis |
Search more.